<?xml version="1.0" encoding="UTF-8"?>
<p id="Par55">Clinical implications of SARS-CoV-2 infection on PD are largely speculative apart from two case series and case reports
 <sup>
  <xref ref-type="bibr" rid="CR45">45</xref>,
  <xref ref-type="bibr" rid="CR46">46</xref>
 </sup>. A community-based case control study in Italy of 12 PD COVID-19 cases suggested substantial worsening of motor and non-motor symptoms during mild to moderate COVID-19 illness, independent of age and disease duration
 <sup>
  <xref ref-type="bibr" rid="CR144">144</xref>
 </sup>, in line with an original case report series by Antonini et al. In another survey across the Lombardy region of Italy, 105 probable COVID-19 cases were identified and the authors concluded that the risk, morbidity, and mortality in patients with mild-to moderate PD with COVID-19 did not differ from the general population
 <sup>
  <xref ref-type="bibr" rid="CR145">145</xref>
 </sup>. Several viewpoints and editorials have been published on the topic in addition to extensive coverage in social media and journal viewpoint papers
 <sup>
  <xref ref-type="bibr" rid="CR146">146</xref>â€“
  <xref ref-type="bibr" rid="CR151">151</xref>
 </sup>.
</p>
